𝔖 Bobbio Scriptorium

✦ LIBER ✦

A prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne

Book ID: 116588286
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 49 KB
Volume: 66
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2011.11.045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A split-face clinical trial to compare t

A split-face clinical trial to compare the safety and efficacy of two topical acne treatments in subjects with mild to moderate acne vulgaris

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A 4-week, randomized, double-blind, para

A 4-week, randomized, double-blind, parallel group trial evaluating the efficacy and tolerability of sebum control product in male and female subjects with oily skin appearance and mild to moderate acne vulgaris

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficacy and tolerability of two formula

Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: An 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial

✍ Sang-Hyun Kim; Woo-Young Chung; Joo-Hee Zo; Myung-A Kim; Hyuk-Jae Chang; Young-S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB

An open label study evaluating the safet

An open label study evaluating the safety and efficacy of a 16 week treatment regimen of alefacept in adults with moderate to severe atopic dermatitis

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

249: A Randomized, Open-Label Study To C

249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency

✍ A. Zuckermann; A. Keogh; M.G. Crespo-Leiro; D. Mancini; F. Gonzalez-Vilchez; L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB